Western Occupational & Environmental Medical Association
Leading Occupational & Environmental Medicine

Opioid Prescribing: New FDA Labeling and New Guidelines

This webinar will review current data and recommendations/guidelines from regulators and professional societies on the use of opioids and chronic pain. The risk vs. benefit analysis will be framed as an essential element of treatment decisions and thus emphasis will be placed on close attention to current data of risks compared with the benefits associated with chronic opioid prescribing. Recommendations from regulatory organizations including the recent labelling of chronic opioids by the FDA as well as recently revised model policy on opioid prescribing by the Federation of State Medical Boards will be reviewed.